Latest News and Press Releases

  Brussels, BELGIUM, August 18, 2006 - Time 07.00 CEST: Newly diagnosed epilepsy patients in Europe with partial onset seizures can now benefit from first-line treatment with Keppra®...

Keppra® krijgt Europese goedkeuring voor monotherapie     Brussel, België, 18 augustus 2006 - 07.00 uur CEST:  Epilepsiepatiënten met een nieuwe diagnose van aanvallen met partieel...

The multivendor solution improves user experience, enhances customer loyalty and helps to reduce churn   Espoo, Finland - Nokia has delivered its device management solution, centered around the...

Orkla ASA has today on 17 August 2006 bought 200 000 Orkla shares at a price of NOK 296.70 per share. A broker has executed the transaction.   Orkla's total holding of own shares after this...

DNO ASA has today increased funding under bond loan facility DNO08 ( ISIN NO0010302649 ) by NOK 100 mill. The loan drawdown has been arranged by Fearnley Fonds...

DNO ASA has today increased funding under bond loan facility DNO08 ( ISIN NO0010302649 ) by NOK 100 mill. The loan drawdown has been arranged by Fearnley Fonds...

Orkla ASA har i dag den 17. august 2006 kjøpt 200 000 egne aksjer gjennom megler til kurs kr 296,70 pr. aksje. Orklas beholdning av egne aksjer etter kjøpet er 2 292 799 aksjer.   ...

Oslo, Norway,  18 August 2006   PhotoCure's study for treatment of acne is published in the British Journal of Dermatology (BJD). The study was performed in 2005 at three Nordic centres,...

Oslo, 18. august 2006   Akne studie publisert i British Journal of Dermatology   PhotoCures første kliniske studie for behandling av akne (kviser) har blitt publisert i...

Novo A/S has hereby achieved its objective of reducing its ownership of Novo Nordisk A/S to a long-term target level of around 25.5%, equal to the level of Novo A/S' ownership of Novo Nordisk A/S...